Climb Bio adopts 2021 Equity Incentive Plan with 5.2M share reserve

Climb Bio's board adopted and stockholders approved a new equity incentive plan effective July 29, 2021, authorizing 5.2 million shares for employee, director and consultant compensation. The plan includes automatic annual increases of 5% for ten years, providing a substantial equity pool for talent retention and incentive alignment.